Opportunity Information: Apply for RFA CK 12 001
Apply for RFA CK 12 001
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Evaluation of Dengue Epidemiology, Outcomes, and Prevention in Sentinel Surveillance and Research Sites in Puerto Rico" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Jan 30, 2012 and posted on Jan 3, 2012.
- Applicants must submit their applications by Mar 5, 2012 by 500 PM U.S. Eastern Time. On time submission requires that electronic applications be error free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 500 PM U.S. Eastern Time. Note HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,200,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The only organizations that can perform the work required in the cooperative agreement are the Ponce School of Medicine and Health Sciences and the University of Puerto Rico School of Medicine.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (RFA CK 12 001) is a discretionary cooperative agreement focused on strengthening and evaluating dengue surveillance and prevention work in Puerto Rico through sentinel surveillance and research sites. The overall purpose is to advance research and evaluation of dengue prevention strategies by improving understanding of dengue epidemiology on the island, tracking clinical outcomes, and using structured, site-based data to assess how well prevention approaches are working in real-world settings. As a cooperative agreement, the project is intended to be carried out with substantial involvement from CDC, meaning CDC would not only provide funding but would also collaborate closely on technical direction, data needs, and evaluation priorities so that findings can directly inform public health practice.
The opportunity sits within the health activity category and is tied to CFDA 93.283 (CDC Investigations and Technical Assistance). CDC anticipated making a single award under this announcement, with an estimated total funding level of $1,200,000. The notice lists no cost sharing or matching requirement, which means the recipient would not be required to contribute non-federal funds as a condition of the award. The announcement does not specify an award ceiling or floor (both are listed as 0), a common way of indicating that the formal funding bounds were not stated in that field even though an overall estimated total amount was provided.
Eligibility was highly limited: the only organizations permitted to apply were the Ponce School of Medicine and Health Sciences and the University of Puerto Rico School of Medicine. That restriction signals that CDC intended this work to be performed by institutions already positioned to operate or partner with the relevant surveillance and clinical research infrastructure in Puerto Rico, including relationships with health care facilities and the capacity to manage field epidemiology activities, data collection, and outcome evaluation at sentinel sites.
Key administrative details include the original posting date of January 3, 2012, with the application due date (original and current closing date) set for March 5, 2012, by 5:00 PM U.S. Eastern Time. Applications were required to be submitted electronically through Grants.gov and validated in eRA Commons by the deadline. The announcement emphasized that submissions had to be error-free and fully validated by the cutoff time, and that CDC submission procedures did not allow an additional post-deadline error-correction window. The opportunity was archived on March 6, 2012, indicating the competition period had closed.
For applicant support, CDC directed technical and submission-related questions to the Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), with a general inquiries phone number provided (770-488-2700). In practical terms, this opportunity reflects CDCs intent at the time to concentrate dengue research and evaluation capacity in Puerto Rico within a small number of specialized academic medical centers, leveraging sentinel surveillance sites to generate actionable evidence on dengue patterns, disease outcomes, and the effectiveness of prevention strategies.
Frequently Asked Questions (FAQs)
What is the funding opportunity?
This is a CDC discretionary cooperative agreement funding opportunity, RFA CK 12 001, focused on strengthening and evaluating dengue surveillance and prevention work in Puerto Rico through sentinel surveillance and research sites.
What is the main purpose of this cooperative agreement?
The overall purpose is to advance research and evaluation of dengue prevention strategies in Puerto Rico by improving understanding of dengue epidemiology, tracking clinical outcomes, and using structured, site-based data to assess how well prevention approaches perform in real-world settings.
What types of activities are emphasized in this opportunity?
The announcement emphasizes sentinel surveillance and research sites, structured site-based data collection, improved epidemiologic understanding of dengue on the island, tracking clinical outcomes, and evaluation of dengue prevention strategies.
Where is the work intended to take place?
The work is intended to focus on Puerto Rico, with dengue surveillance and prevention evaluation conducted through sentinel surveillance and research sites on the island.
What does it mean that this is a "cooperative agreement"?
As a cooperative agreement, CDC planned to have substantial involvement in the project. CDC would not only provide funding, but also collaborate closely on technical direction, data needs, and evaluation priorities so findings can directly inform public health practice.
How involved would CDC be during the project?
The announcement indicates substantial CDC involvement, including collaboration on technical direction, defining data needs, and shaping evaluation priorities, with the goal of producing findings that directly inform public health practice.
What is the program or CFDA number associated with this opportunity?
The opportunity is tied to CFDA 93.283, CDC Investigations and Technical Assistance.
What activity category does this opportunity fall under?
The notice places this opportunity within the health activity category.
How many awards did CDC anticipate making?
CDC anticipated making a single award under this announcement.
What was the estimated total funding amount?
The estimated total funding level listed in the notice is $1,200,000.
Was cost sharing or matching required?
No. The notice lists no cost sharing or matching requirement, meaning the recipient would not be required to contribute non-federal funds as a condition of the award.
Is there an award ceiling or floor stated in the announcement?
The announcement does not specify an award ceiling or floor; both fields are listed as 0. The notice still provides an estimated total funding amount of $1,200,000, but formal bounds were not stated in that particular field.
Who was eligible to apply?
Eligibility was limited to two organizations: the Ponce School of Medicine and Health Sciences and the University of Puerto Rico School of Medicine.
Could organizations outside those two institutions apply?
No. Based on the eligibility restriction stated, only the Ponce School of Medicine and Health Sciences and the University of Puerto Rico School of Medicine were permitted to apply.
Why was eligibility restricted to those specific institutions?
The notice suggests CDC intended the work to be performed by institutions already positioned to operate or partner with dengue surveillance and clinical research infrastructure in Puerto Rico, including relationships with health care facilities and the capacity to manage field epidemiology activities, data collection, and outcome evaluation at sentinel sites.
What was the original posting date?
The original posting date was January 3, 2012.
What was the application due date and time?
The application due date (original and current closing date) was March 5, 2012, by 5:00 PM U.S. Eastern Time.
How were applications required to be submitted?
Applications were required to be submitted electronically through Grants.gov and validated in eRA Commons by the deadline.
What does "validated in eRA Commons" imply for applicants?
Based on the notice, submission was not considered complete unless the application was both submitted through Grants.gov and successfully validated in eRA Commons by the deadline.
Were applicants allowed to fix errors after the deadline?
No. The announcement emphasized that submissions had to be error-free and fully validated by the cutoff time, and that CDC submission procedures did not allow an additional post-deadline error-correction window.
When was the opportunity archived?
The opportunity was archived on March 6, 2012, indicating the competition period had closed.
Who could applicants contact for technical or submission-related questions?
CDC directed technical and submission-related questions to the Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS).
What phone number was provided for general inquiries?
The general inquiries phone number provided was 770-488-2700.
What is the practical public health intent of this opportunity (as described)?
In practical terms, the opportunity reflects CDC's intent at the time to concentrate dengue research and evaluation capacity in Puerto Rico within a small number of specialized academic medical centers, leveraging sentinel surveillance sites to generate actionable evidence on dengue patterns, disease outcomes, and the effectiveness of prevention strategies.
What kinds of outcomes or findings was CDC aiming to support?
The announcement highlights improving understanding of dengue epidemiology, tracking clinical outcomes, and evaluating how well prevention approaches work in real-world settings using structured, site-based data, with findings intended to inform public health practice.
Browse more opportunities from the same category: Health
Next opportunity: Planning a Partnership Model for a Giant Segmented Mirror Telescope
Previous opportunity: Market Development Cooperator Program 2012
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 12 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 12 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Operations Research (Implementation Science) for Strengthening Program Implementation through the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for RFA GH 12 008 Funding Number: RFA GH 12 008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Provision of Comprehensive HIV/AIDS Care, Treatment and Prevention Services in indigenous Health Facilities in the Republic of Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1209 Funding Number: CDC RFA GH12 1209 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| A Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Apply for RFA DD 12 002 Funding Number: RFA DD 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34) Apply for PAR 12 071 Funding Number: PAR 12 071 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Clinical Trials in Organ Transplantation in Children (U01) Apply for RFA AI 12 005 Funding Number: RFA AI 12 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Identifying Reasons for Racial/Ethnic Disparities with Completing the HPV Vaccine Series among Adolescent Females Apply for RFA IP 12 004 Funding Number: RFA IP 12 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Intervention Study to Increase Use of Standing Orders Programs for Vaccinating Adults in Physician Office Settings Apply for RFA IP 12 005 Funding Number: RFA IP 12 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Affordable Care Act Maternal, Infant, and Early Childhood Home Visiting Research Network Apply for HRSA 12 158 Funding Number: HRSA 12 158 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Multidisciplinary Clinical Research Centers (P60) Apply for RFA AR 13 001 Funding Number: RFA AR 13 001 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| NINDS Exploratory Clinical Trials for Small Business (STTR R42) Apply for PAR 12 072 Funding Number: PAR 12 072 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| NINDS Exploratory Clinical Trials for Small Business (SBIR R44) Apply for PAR 12 073 Funding Number: PAR 12 073 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NINDS Competing Renewal Awards of STTR Phase II Grants (Phase IIB) for Exploratory Clinical Trials (STTR R42) Apply for PAR 12 074 Funding Number: PAR 12 074 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Competing Renewal Awards of SBIR Phase II Grants (Phase IIB) for Exploratory Clinical Trials (SBIR R44) Apply for PAR 12 075 Funding Number: PAR 12 075 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Competing Renewal Awards of SBIR Phase II (Phase IIB) Grants (SBIR R44) Apply for PAR 12 077 Funding Number: PAR 12 077 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Competing Renewal Awards of STTR Phase II (Phase IIB) Grants (STTR R42) Apply for PAR 12 076 Funding Number: PAR 12 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CHILDRENS HEALTH INSURANCE PROGRAM REAUTHORIZATION ACT (CHIPRA)PROSPECTIVE PAYMENT SYSTEM (PPS) FOR FEDERALLY QUALIFIED HEALTH CENTERS (FQHCs) AND RURAL HEALTH CLINICS (RHCs) TRANSITION GRANTS SECOND RELEASE Apply for CMS 1Z0 12 001 Funding Number: CMS 1Z0 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $500,000 |
| Molecular Characterization of Salivary Gland Tumors (R21) Apply for RFA DE 12 012 Funding Number: RFA DE 12 012 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Molecular Characterization of Salivary Gland Tumors (R01) Apply for RFA DE 12 011 Funding Number: RFA DE 12 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Conducting Research on Moderate Acute Malnutrition in Humanitarian Emergencies Apply for RFA GH 12 006 Funding Number: RFA GH 12 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Service Area Competition Additional Area (SAC AA) (Anchorage, AK) Apply for HRSA 12 169 Funding Number: HRSA 12 169 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 12 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.